Compare SID & BLFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SID | BLFS |
|---|---|---|
| Founded | 1941 | 1987 |
| Country | Brazil | United States |
| Employees | N/A | N/A |
| Industry | Steel/Iron Ore | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.3B |
| IPO Year | 2002 | 2013 |
| Metric | SID | BLFS |
|---|---|---|
| Price | $1.08 | $30.12 |
| Analyst Decision | Strong Sell | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | $1.40 | ★ $32.00 |
| AVG Volume (30 Days) | ★ 2.5M | 1.6M |
| Earning Date | 05-06-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 77.27 |
| EPS | N/A | ★ 0.02 |
| Revenue | N/A | ★ $96,214,000.00 |
| Revenue This Year | $1.71 | $19.73 |
| Revenue Next Year | $1.58 | $17.82 |
| P/E Ratio | ★ N/A | $1,538.50 |
| Revenue Growth | N/A | ★ 16.97 |
| 52 Week Low | $0.89 | $17.86 |
| 52 Week High | $2.20 | $32.23 |
| Indicator | SID | BLFS |
|---|---|---|
| Relative Strength Index (RSI) | 54.18 | 62.45 |
| Support Level | $0.89 | $23.86 |
| Resistance Level | $1.31 | N/A |
| Average True Range (ATR) | 0.04 | 1.20 |
| MACD | 0.02 | 0.10 |
| Stochastic Oscillator | 79.55 | 63.02 |
Companhia Siderurgica Nacional is an integrated steel producer. together with its subsidiaries operates in five main business segments: Steel industry: production and marketing of flat and long steels; Mining: extraction, processing and marketing of iron ore, tin, limestone and dolomite; Cement: production and commercialization of bagged and bulk cement, in addition to aggregates, concrete, and other related products; Energy: generation and sale of energy from almost all renewable sources; and Logistics: participations port concessions and fleets of road transport vehicles. The group generates the majority of its revenue from the Steel industry segment. Geographically, it derives a majority of revenue from Asia.
BioLife Solutions Inc is a life sciences company that develops, manufactures, and markets bioproduction products and services that are designed to improve quality and de-risk biologic manufacturing, distribution, and transportation in the cell and gene therapy ("CGT") industry. The company provides solutions such as Cell Processing, Cold Chain, and Thawing. The company generates the majority of its revenue from Cell Processing through the biopreservation product "CryoStor". Geographically the company generates the majority of its revenue from the United States.